Wikidata entity: Q20948663
C₁₄H₁₉BCl₂N₂O₄ (P274)
Quantities
| P2067 | mass | 360.081 |
| P3780 | active ingredient in | ... | Q29006222 (Ninlaro) | Ninlaro |
| P233 | canonical SMILES | String | B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | B([C@H](CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284878 (Լյարդի ախտահարման հավանականության E կատեգորիա) | Լյարդի ախտահարման հավանականության E կատեգորիա |
| P2175 | medical condition treated | ... | Q467635 (multiple myeloma) | multiple myeloma |
| P2175 | medical condition treated | ... | Q816798 (amyloidosis) | amyloidosis |
| P129 | physically interacts with | ... | Q21108543 (Proteasome 26S subunit, non-ATPase 14) | Proteasome 26S subunit, non-ATPase 14 |
| P129 | physically interacts with | ... | Q21111454 (Proteasome 20S subunit alpha 3) | Proteasome 20S subunit alpha 3 |
| P129 | physically interacts with | ... | Q21112900 (Proteasome 20S subunit alpha 6) | Proteasome 20S subunit alpha 6 |
| P129 | physically interacts with | ... | Q21113927 (Proteasome 20S subunit beta 10) | Proteasome 20S subunit beta 10 |
| P129 | physically interacts with | ... | Q21118582 (Proteasome 20S subunit beta 2) | Proteasome 20S subunit beta 2 |
| P129 | physically interacts with | ... | Q21119744 (Proteasome 20S subunit beta 8) | Proteasome 20S subunit beta 8 |
| P129 | physically interacts with | ... | Q21120458 (Proteasome 20S subunit beta 5) | Proteasome 20S subunit beta 5 |
| P129 | physically interacts with | ... | Q21124345 (Proteasome 20S subunit beta 6) | Proteasome 20S subunit beta 6 |
| P129 | physically interacts with | ... | Q21124965 (Proteasome 20S subunit alpha 5) | Proteasome 20S subunit alpha 5 |
| P129 | physically interacts with | ... | Q21124971 (Proteasome 20S subunit alpha 8) | Proteasome 20S subunit alpha 8 |
| P129 | physically interacts with | ... | Q21126046 (Proteasome subunit beta 11) | Proteasome subunit beta 11 |
| P129 | physically interacts with | ... | Q21126857 (Proteasome 20S subunit alpha 2) | Proteasome 20S subunit alpha 2 |
| P129 | physically interacts with | ... | Q21172182 (Proteasome subunit beta 1) | Proteasome subunit beta 1 |
| P129 | physically interacts with | ... | Q21174069 (Proteasome 26S subunit, non-ATPase 1) | Proteasome 26S subunit, non-ATPase 1 |
| P129 | physically interacts with | ... | Q21208034 (Proteasome 20S subunit alpha 7) | Proteasome 20S subunit alpha 7 |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q166774 (protease inhibitor) | protease inhibitor |
| P2868 | subject has role | ... | Q2853144 (antineoplastic) | antineoplastic |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | ixazomib | ??? |
Why not click here or view trends?
log id: 59866